Vyne Therapeutics (VYNE) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.3
-0.27
-0.23
-0.19

Details

Expected EPS
-0.28835
Actual EPS
-0.2
Surprise EPS
0.09
Surprise Percent
+30.64%

Description

⁨Vyne Therapeutics⁩ (⁦VYNE⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts